USE OF THE COMPLEX BETWEEN PROSTATE SPECIFIC ANTIGEN AND α1-PROTEASE INHIBITOR FOR SCREENING PROSTATE CANCER-Reference-Cited by-同舟云学术

USE OF THE COMPLEX BETWEEN PROSTATE SPECIFIC ANTIGEN AND α1-PROTEASE INHIBITOR FOR SCREENING PROSTATE CANCER

Published:2000-12 Issue:6 Volume:164 Page:1956-1960
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

FINNE PATRIK¹,ZHANG WAN-MING¹,AUVINEN ANSSI¹,LEINONEN JARI¹,MÄÄTTÄNEN LIISA¹,RANNIKKO SAKARI¹,TAMMELA TEUVO L.J.¹,STENMAN ULF-HÅKAN¹

Affiliation:

1. From the Departments of Clinical Chemistry and Urology, Helsinki University Central Hospital, STUK-Radiation and Nuclear Safety Authority, Helsinki, School of Public Health, University of Tampere Finnish Cancer Registry and Division of Urology, Tampere University Hospital, Tampere, Finland

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference19 articles.

1. Cancer incidence in five continents;Parkin,1997

2. Optimized strategy for detection of early stage, curable prostate cancer: role of prescreening with prostate-specific antigen;Labrie;Clin Invest Med,1993

3. The European Randomized Study of Screening for Prostate Cancer (ERSPC);Schröder;Br J Urol,1997

4. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer;Catalona;N Engl J Med,1991

5. European randomized study of prostate cancer screening: first-year results of the Finnish trial;Määttänen;Br J Cancer,1999

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic Importance of Selected Protein Serum Markers in the Primary Diagnostics of Prostate Cancer;Urologia Internationalis;2015

2. Complex formation between human prostate-specific antigen and protease inhibitors in mouse plasma;The Prostate;2009-11-20

3. Proximity Ligation Measurement of the Complex between Prostate Specific Antigen and α1-Protease Inhibitor;Clinical Chemistry;2009-09-01

4. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers;Clinical Chemistry;2008-12-01

5. Prostate-specific antigen and prostate cancer: prediction, detection and monitoring;Nature Reviews Cancer;2008-04